Valuation: Shivalik Rasayan Limited

Market Cap 4.79B 50.55M 45.16M 41.48M 37.67M 70.75M 72.52M 495M 199M 2.53B 190M 186M 8.01B P/E 2025
59.1x
P/E 2026 28.2x
Enterprise Value 5.67B 59.88M 53.5M 49.14M 44.63M 83.81M 85.92M 587M 236M 2.99B 225M 220M 9.49B EV / Sales 2025
3.4x
EV / Sales 2026 1.21x
Free-Float
46.1%
Yield 2025
0.08%
Yield 2026 0.23%
Aug. 14 Shivalik Rasayan Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
Jul. 23 Shivalik Rasayan Limited announced that it expects to receive INR 152.25 million in funding from Bishnoi Exports Private Limited, Growel Remedies Limited, Kim Ginnerup ApS and other investors CI
May. 27 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
May. 27 Shivalik Rasayan Limited Announces Resignation of Sanjay Bansal as Non-Executive Director, Effective May 27, 2026 CI
May. 27 Shivalik Rasayan Limited Recommends Final Dividend for the Financial Year 2025-26, Payable on or After October 15, 2026 CI
May. 27 Shivalik Rasayan Ltd March-quarter consol net profit 45.3 million rupees RE
Feb. 13 Shivalik Rasayan Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
Nov. 14 Shivalik Rasayan Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25-09-29 Shivalik Rasayan Limited Approves the Re-Designation of Mr. Ashwani Kumar Sharma as a Non-Executive, Non-Independent Director CI
25-08-12 Shivalik Rasayan Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
25-05-30 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
25-05-29 Shivalik Rasayan Limited announces Annual dividend, payable on October 27, 2025 CI
25-04-23 Medicamen Biotech Limited announced that it has received INR 535.6816 million in funding from Kim Ginnerup ApS, Shivalik Rasayan Limited, VERALOGIX HOLDINGS LTD and other investors CI
1 day+2.41%
1 week-2.20%
Current month+1.50%
1 month-22.56%
3 months+23.08%
6 months+16.34%
Current year-14.57%
1 week 282.2
Extreme 282.2
320.95
1 month 282.2
Extreme 282.2
399.9
Current year 206
Extreme 206
437.9
1 year 206
Extreme 206
474.2
3 years 206
Extreme 206
873.6
5 years 206
Extreme 206
1,196.8
10 years 75.4
Extreme 75.4
1,196.8
Manager TitleAgeSince
Chief Executive Officer 64 2018-11-16
Director of Finance/CFO - 2001-10-31
Compliance Officer - 2017-07-31
Director TitleAgeSince
Chairman 62 2002-02-22
Director/Board Member 67 2003-07-17
Director/Board Member - 2018-11-12
Date Insider Type Main position Quantity % Market Cap. Importance
7/1/24 Don 21,500 0.1382%
6/26/24 Sell 108,500 0.6973%
Change 5-day change 1-year change 3-year change Capi.($)
+2.41%-2.20%-31.19%-55.89% 49.39M
-1.26%-0.12%+26.94%+26.63% 33.54B
-2.90%-2.23%+39.61%+44.51% 18.21B
+2.69%+1.12%-9.31%+35.56% 17.42B
-0.26%+2.43%-7.02%-14.75% 14.48B
+0.11%-.--%-.--%-.--% 12.96B
-1.87%-2.59%+3.72%+5.30% 10.85B
-0.78%-8.27%-6.49%+137.66% 9.06B
-0.22%-.--%-.--%-.--% 8.3B
-0.34%+1.33% - - 7.95B
Average -0.19%-0.29%+1.81%+19.89% 13.28B
Weighted average by Cap. -0.51%+0.82%+10.74%+27.32%

Financials

2025 2026
Net sales 3.1B 32.68M 29.19M 26.82M 24.36M 45.74M 46.89M 320M 129M 1.63B 123M 120M 5.18B 3.62B 38.18M 34.11M 31.33M 28.45M 53.43M 54.77M 374M 150M 1.91B 143M 140M 6.05B
Net income 167M 1.76M 1.57M 1.45M 1.31M 2.47M 2.53M 17.27M 6.95M 88.12M 6.62M 6.47M 279M 124M 1.31M 1.17M 1.07M 976K 1.83M 1.88M 12.82M 5.16M 65.45M 4.91M 4.81M 207M
Net Debt 768M 8.1M 7.24M 6.65M 6.04M 11.34M 11.63M 79.37M 31.93M 405M 30.41M 29.76M 1.28B 884M 9.33M 8.34M 7.66M 6.96M 13.06M 13.39M 91.44M 36.78M 467M 35.04M 34.29M 1.48B
Projected Income Statement - Annual - Shivalik Rasayan Limited
Logo Shivalik Rasayan Limited
Shivalik Rasayan Limited is an India-based company. The Company’s segments are engaged in agrochemicals, active pharma ingredients (API), and pharma formulation. It is the producer of Malathion Technical and Dimethoate Technical. Malathion Technical is a non-systemic, wide spectrum organophosphorus (OP) based contact insecticide. Dimethoate Technical is used in preparation of formulations used in the control of a range of insects and mites. It also manufactures organophosphorus-based insecticides and chemicals. It has a diverse product range and product mix in order to serve consumer requirements. The APIs are being developed and manufactured in the niche area of oncology, ARVs, cardiovascular, metabolic disorders and immunology. It offers solutions from product selection to development to commercialization for a range of oncology and non-oncology products. The Company’s oncology products include Azacitidine, Busulfan, Bortezomib, and various others.
Employees
342
Date Price Change Volume
26-11-03 ₹304.00 +2.41% 11,256
26-11-02 ₹296.85 -0.88% 4,837
26-10-30 ₹299.50 -4.13% 7,486
26-10-29 ₹312.40 -1.01% 2,904
26-10-28 ₹315.60 -1.67% 915
  1. Stock Market
  2. Stocks
  3. SHIVALIK Stock